Abstract
Background
Angiosarcoma of the breast is rare. The purpose of the present study was to evaluate the clinicopathologic characteristics and the clinical outcomes of patients with primary breast angiosarcoma.
Methods
We analyzed the clinicopathologic factors of patients with angiosarcoma of the breast treated between 1997 and 2010 at the Samsung Medical Center. We reviewed the related demographic data, preoperative imaging studies, method of histologic confirmation, tumor size, histologic grades, status of hormonal receptors, treatment modality, and survival data.
Results
Nine women with angiosarcoma of the breast were identified. The median age of patients with primary angiosarcoma of the breast at diagnosis was 31 years (range: 19–63 years), and the median tumor size was 9.0 cm (range: 3.5–10.7 cm). Seven patients (77.7%) died within a median follow-up of 46.7 months (range: 3.9–63.3 months), and all deaths were directly attributed to angiosarcoma. Overall, the median time from diagnosis of angiosarcoma to death was 46.8 months (range: 8.21–63.3 months). The 5 year overall survival with angiosarcoma was 42.9%.
Conclusions
Primary angiosarcoma of the breast is a rare malignancy with a poor prognosis, even with complete resection. Chemotherapy and radiation therapy have limited value as treatments to date. Total mastectomy appears to be the most appropriate and beneficial treatment. More aggressive surgical management should be considered, and future clinical research should explore the most appropriate adjuvant therapy in the treatment of angiosarcoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Huang J, Mackillop WJ (2001) Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 92:172–180
Vorburger SA, Xing Y, Hunt KK et al (2005) Angiosarcoma of the breast. Cancer 104:2682–2688
Zelek L, Llombart-Cussac A, Terrier P et al (2003) Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol 21:2583–2588
Marchal C, Weber B, de Lafontan B et al (1999) Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys 44:113–119
Chen KT, Kirkegaard DD, Bocian JJ (1980) Angiosarcoma of the breast. Cancer 46:368–371
Donnell RM, Rosen PP, Lieberman PH et al (1981) Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol 5:629–642
Hodgson NC, Bowen-Wells C, Moffat F et al (2007) Angiosarcomas of the breast: a review of 70 cases. Am J Clin Oncol 30:570–573
West JG, Qureshi A, West JE et al (2005) Risk of angiosarcoma following breast conservation: a clinical alert. Breast J 11:115–123
Luini A, Gatti G, Diaz J et al (2007) Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature. Breast Cancer Res Treat 105:81–85
Kiluk JV, Yeh KA (2005) Primary angiosarcoma of the breast. Breast J 11:517–518
McGowan TS, Cummings BJ, O’Sullivan B et al (2000) An analysis of 78 breast sarcoma patients without distant metastases at presentation. Int J Radiat Oncol Biol Phys 46:383–390
Lee SD, Han BK, Yang JH et al (2000) Angiosarcoma of the breast: a report of 2 cases. J Korean Surg Soc 58:851–856
Hunter TB, Martin PC, Dietzen CD et al (1985) Angiosarcoma of the breast two case reports and a review of the literature. Cancer 56:2099–2106
Merino MJ, Carter D, Berman M (1983) Angiosarcoma of the breast. Am J Surg Pathol 7:53–60
Cafiero F, Gipponi M, Peressini A et al (1996) Radiation-associated angiosarcoma: diagnostic and therapeutic implications—two case reports and a review of the literature. Cancer 77:2496–2502
Feigenberg SJ, Mendenhall NP, Reith JD et al (2002) Angiosarcoma after breast-conserving therapy: experience with hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 52:620–626
Mandrell J, Mehta S, McClure S (2010) Atypical vascular lesion of the breast. J Am Acad Dermatol 63:337–340
Scow JS, Reynolds CA, Degnim AC et al (2010) Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol 101:401–407
Monroe AT, Feigenberg SJ, Mendenhall NP (2003) Angiosarcoma after breast-conserving therapy. Cancer 97:1832–1840
Nakamura R, Nagashima T, Sakakibara M et al (2007) Angiosarcoma arising in the breast following breast-conserving surgery with radiation for breast carcinoma. Breast Cancer 14:245–249
Sher T, Hennessy BT, Valero V et al (2007) Primary angiosarcomas of the breast. Cancer 110:173–178
Yang WT, Hennessy BT, Dryden MJ et al (2007) Mammary angiosarcomas: imaging findings in 24 patients. Radiology 242:725–734
Kim YJ, Lee KH, Cho YU et al (2006) MR imaging and spectroscopic findings of primary angiosarcoma of the breast: a case report. J Korean Radiol Soc 54:557–560
Nagano T, Yamada Y, Ikeda T et al (2007) Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer 110:648–651
Blay JY, Le Cesne A (2009) Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven. Oncologist 14:1013–1020
Perez-Ruiz E, Ribelles N, Sanchez-Munoz A et al (2009) Response to paclitaxel in a radiotherapy-induced breast angiosarcoma. Acta Oncol 48:1078–1079
Acknowledgment
This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (A092255).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bae, S.Y., Choi, MY., Cho, D.H. et al. Large Clinical Experience of Primary Angiosarcoma of the Breast in a Single Korean Medical Institute. World J Surg 35, 2417–2421 (2011). https://doi.org/10.1007/s00268-011-1225-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-011-1225-1